Abstract
This study investigates the potential of bee pollen protein hydrolysate (BPPH) as a natural source of bioactive peptides capable of inhibiting dipeptidyl peptidase IV (DPP-IV) for the management of type 2 diabetes mellitus (T2DM), a metabolic disorder characterized by insulin resistance and hyperglycemia. BPPH was generated through pepsin–pancreatin digestion, followed by ultrafiltration and RP-HPLC purification. LC-Q-TOF-MS/MS analysis identified Ala-Thr-His-Ala-Leu-Leu-Ala (ATHALLA, AA-7) as a predominant peptide associated with DPP-IV inhibitory activity. AA-7 exhibited strong DPP-IV inhibitory activity (IC50 = 52.63 ± 2.32 µM) relative to the reference inhibitor diprotin A (IC50 = 22.4 ± 1.29 µM). Molecular docking predicted stable binding of AA-7 within the DPP-IV catalytic pocket, mediated by hydrogen bonding and hydrophobic interactions with key residues. AA-7 also modulated glucose uptake in Caco-2 cells, influencing SGLT1 and GLUT2 gene expression in a dose-dependent manner. Docking analysis suggested potential interactions with selected SGLT1 and GLUT2 residues, providing structural support for the observed cellular responses rather than definitive mechanistic evidence. In silico ADMET analysis indicated poor passive membrane permeability and limited predicted intestinal absorption, along with minimal CYP450 interactions and low predicted toxicity, highlighting potential pharmacokinetic limitations while supporting a favorable safety profile. These findings highlight AA-7 as a dual-action peptide with demonstrated DPP-IV inhibitory activity and the ability to modulate glucose transport in vitro, supporting the potential of bee-pollen-derived peptides for glycemic regulation and functional food or nutraceutical applications.
Data availability
The authors confirm that the data supporting the findings of this study are available within the article and its Supplementary material. Raw data that support the findings of this study are available from the corresponding author, upon reasonable request.
References
Galicia-Garcia, U. et al. Pathophysiology of type 2 diabetes mellitus. Int. J. Mol. Sci. 21, 6275. https://doi.org/10.3390/ijms21176275 (2020).
Ogurtsova, K. et al. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res. Clin. Pract. 218, 40–50. https://doi.org/10.1016/j.diabres.2017.03.024 (2017).
Wu, Y., Ding, Y., Tanaka, Y. & Zhang, W. Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention. Int. J. Med. Sci. 11, 1185–1200. https://doi.org/10.7150/ijms.10001 (2014).
Li, Y. et al. Diabetic vascular diseases: molecular mechanisms and therapeutic strategies, signal transduct. Target. Ther. 8, 152. https://doi.org/10.1038/s41392-023-01400-z (2023).
Ahrén, B. & Schmitz, O. GLP-1 receptor agonists and DPP-4 inhibitors in the treatment of type 2 diabetes. Horm. Metab. Res. 36, 867–876. https://doi.org/10.1055/s-2004-826178 (2004).
Barnett, A. DPP-4 inhibitors and their potential role in the management of type 2 diabetes. Int. J. Clin. Pract. 60, 1454–1470. https://doi.org/10.1111/j.1742-1241.2006.01178.x (2006).
Derosa, G. & Maffioli, P. Dipeptidyl peptidase-4 inhibitors: 3 years of experience. Diabetes Technol. Ther. 14, 350–364. https://doi.org/10.1089/dia.2011.0204 (2012).
Saini, K., Sharma, S. & Khan, Y. DPP-4 inhibitors for treating T2DM - hype or hope? An Analysis based on the current literature. Front. Mol. Biosci. 10, 1130625. https://doi.org/10.3389/fmolb.2023.1130625 (2023).
Li, N. et al. Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus. Eur. J. Med. Chem. 151, 145–157. https://doi.org/10.1016/j.ejmech.2018.03.041 (2018).
Martini, S., Cattivelli, A., Conte, A. & Tagliazucchi, D. Application of a combined peptidomics and in Silico approach for the identification of novel dipeptidyl peptidase-IV-inhibitory peptides in in vitro digested Pinto bean protein extract. Curr. Issues Mol. Biol. 44, 139–151. https://doi.org/10.3390/cimb44010011 (2021).
Amigo, L. & Hernández-Ledesma, B. Current evidence on the bioavailability of food bioactive peptides. Molecules 25, 4479. https://doi.org/10.3390/molecules25194479 (2020).
Yu, J., Chen, G., Jin, Y., Zhang, M. & Wu, T. Research progress of bioactive peptides in improving type II diabetes. Foods 14, 340. https://doi.org/10.3390/foods14030340 (2025).
Gao, J., Gong, H. & Mao, X. Dipeptidyl peptidase-IV inhibitory activity and related molecular mechanism of bovine α-lactalbumin-derived peptides. Molecules 25, 3009. https://doi.org/10.3390/molecules25133009 (2020).
Zhang, Y. et al. Comparison of dipeptidyl peptidase IV-inhibitory activity of peptides from bovine and caprine milk casein by in Silico and in vitro analyses. Int. Dairy. J. 53, 37–44. https://doi.org/10.1016/j.idairyj.2015.10.001 (2016).
Xu, F. et al. Identification and quantification of DPP-IV-inhibitory peptides from hydrolyzed-rapeseed-protein-derived Napin with analysis of the interactions between key residues and protein domains. J. Agric. Food Chem. 67, 3679–3690. https://doi.org/10.1021/acs.jafc.9b01069 (2019).
Zhang, Y. et al. Dipeptidyl peptidase IV-inhibitory peptides derived from silver carp (Hypophthalmichthys molitrix Val.) proteins. J. Agric. Food Chem. 64, 831–839. https://doi.org/10.1021/acs.jafc.5b05429 (2016).
Mu, X., Wang, R., Cheng, C., Ma, Y. & Li, Q. Two novel peptides derived from oat with inhibitory activity against dipeptidyl peptidase-IV: the related mechanism revealed by molecular Docking and in vitro and in situ effects. J. Food Meas. Char. 18, 3087–3099. https://doi.org/10.1007/s11694-024-02387-z (2024).
Wu, W. et al. Exploring dipeptidyl peptidase-IV inhibitory peptides from Tartary buckwheat protein: A study of hydrolysis, fractionation, and molecular interactions. J. Food Sci. 89, 9108–9119. https://doi.org/10.1111/1750-3841.17525 (2024).
Santos-Hernández, M., Cermeño, M., Recio, I. & FitzGerald, R. J. Vitro dipeptidyl peptidase IV inhibitory activity and in situ insulinotropic activity of milk and egg white protein digests. Food Funct. 12, 12372–12380. https://doi.org/10.1039/d1fo00641j (2021).
Velarde-Salcedo, A. J. et al. In vitro Inhibition of dipeptidyl peptidase IV by peptides derived from the hydrolysis of Amaranth (Amaranthus hypochondriacus L.) proteins. Food Chem. 136, 758–764. https://doi.org/10.1016/j.foodchem.2012.08.032 (2013).
Caron, J., Domenger, D., Dhulster, P., Ravallec, R. & Cudennec, B. Using Caco-2 cells as novel identification tool for food-derived DPP-IV inhibitors. Food Res. Int. 92, 113–118. https://doi.org/10.1016/j.foodres.2017.01.002 (2017).
Thakur, M. & Nanda, V. Composition and functionality of bee pollen: A review. Trends Food Sci. Technol. 98, 82–106. https://doi.org/10.1016/j.tifs.2020.02.001 (2020).
El Ghouizi, A. et al. Bee pollen as functional food: insights into its composition and therapeutic properties. Antioxidants 12, 557. https://doi.org/10.3390/antiox12030557 (2023).
Ilie, C. L. et al. Bee pollen extracts: chemical composition, antioxidant properties, and effect on the growth of selected probiotic and pathogenic bacteria. Antioxidants 11, 959. https://doi.org/10.3390/antiox11050959 (2022).
Saisavoey, T., Sangtanoo, P., Chanchao, C., Reamtong, O. & Karnchanatat, A. Identification of novel anti-inflammatory peptides from bee pollen (Apis mellifera) hydrolysate in lipopolysaccharide-stimulated RAW264.7 macrophages. J. Apic. Res. 60, 280–289. https://doi.org/10.1080/00218839.2020.1745434 (2020).
Saisavoey, T., Sangtanoo, P., Srimongkol, P., Reamtong, O. & Karnchanatat, A. Hydrolysates from bee pollen could induced apoptosis in human bronchogenic carcinoma cells (ChaGo-K-1). J. Food Sci. Technol. 58, 752–763. https://doi.org/10.1007/s13197-020-04592-2 (2021).
Khongkarat, P., Traiyasut, P., Phuwapraisirisan, P. & Chanchao, C. First report of fatty acids in Mimosa Diplotricha bee pollen with in vitro lipase inhibitory activity. PeerJ 10, e12722. https://doi.org/10.7717/peerj.12722 (2022).
Aursuwanna, T. et al. Investigating the cellular antioxidant and anti-inflammatory effects of the novel peptides in Lingzhi mushrooms. Heliyon 8, e11067. https://doi.org/10.1016/j.heliyon.2022.e11067 (2022).
Sangtanoo, P. et al. Bee pollen peptides as potent tyrosinase inhibitors with anti-melanogenesis effects in murine b16f10 melanoma cells and zebrafish embryos. Sci. Rep. 14, 30834. https://doi.org/10.1038/s41598-024-81495-8 (2024).
Boonmee, A., Srisomsap, C., Karnchanatat, A. & Sangvanich, P. An antioxidant protein in Curcuma Comosa Roxb. Rhizomes. Food Chem. 124, 476–480. https://doi.org/10.1016/j.foodchem.2010.06.057 (2011).
Kamal, H. et al. Inhibitory properties of camel Whey protein hydrolysates toward liver cancer cells, dipeptidyl peptidase-IV, and inflammation. J. Dairy. Sci. 101, 8711–8720. https://doi.org/10.3168/jds.2018-14586 (2018).
Xiong, G. et al. ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Res. 49, W5–W14. https://doi.org/10.1093/nar/gkab255 (2021).
Xu, F. et al. Absorption and metabolism of peptide WDHHAPQLR derived from rapeseed protein and Inhibition of HUVEC apoptosis under oxidative stress. J. Agric. Food Chem. 66, 5178–5189. https://doi.org/10.1021/acs.jafc.8b01620 (2018).
Livak, K. J. & Schmittgen, T. D. T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method, Methods 25 (2001) 402–408. (2001). https://doi.org/10.1006/meth.2001.1262
Yan, Z. et al. Gastrointestinal digestion of food proteins: Anticancer, antihypertensive, anti-obesity, and Immunomodulatory mechanisms of the derived peptides. Food Res. Int. 189, 114573. https://doi.org/10.1016/j.foodres.2024.114573 (2024).
Montoya-Rodríguez, A., Milán-Carrillo, J., Dia, V. P. & Reyes-Moreno, C. González de Mejía, Pepsin-pancreatin protein hydrolysates from extruded Amaranth inhibit markers of atherosclerosis in LPS-induced THP-1 macrophages-like human cells by reducing expression of proteins in LOX-1 signaling pathway. Proteome Sci. 12, 30. https://doi.org/10.1186/1477-5956-12-30 (2014).
Lacroix, I. M. E. & Li-Chan, E. C. Y. Isolation and characterization of peptides with dipeptidyl peptidase-IV inhibitory activity from pepsin-treated bovine Whey proteins. Peptides 54, 39–48. https://doi.org/10.1016/j.peptides.2014.01.002 (2014).
Lacroix, I. M. E. & Li-Chan, E. C. Y. Dipeptidyl peptidase-IV inhibitory activity of dairy protein hydrolysates. Int. Dairy. J. 25, 97–102. https://doi.org/10.1016/j.idairyj.2012.01.003 (2012).
Mojica, L., Chen, K. & de Mejía, E. G. Impact of commercial precooking of common bean (Phaseolus vulgaris) on the generation of peptides, after pepsin-pancreatin hydrolysis, capable to inhibit dipeptidyl peptidase-IV. J. Food Sci. 80, H188–H198. https://doi.org/10.1111/1750-3841.12726 (2015).
Chandrasekaran, S., Luna-Vital, D. & de Mejia, E. G. Identification and comparison of peptides from Chickpea protein hydrolysates using either Bromelain or Gastrointestinal enzymes and their relationship with markers of type 2 diabetes and bitterness. Nutrients 12, 3843. https://doi.org/10.3390/nu12123843 (2020).
You, H. et al. Preparation and identification of dipeptidyl peptidase IV inhibitory peptides from Quinoa protein. Food Res. Int. 156, 1–9. https://doi.org/10.1016/j.foodres.2022.111176 (2022).
Ding, L. et al. Identification and characterization of dipeptidyl peptidase IV inhibitory peptides from wheat gluten proteins. J. Cereal Sci. 103, 1–7. https://doi.org/10.1016/j.jcs.2021.103396 (2022).
Kumar, A., Kumar, M. H. S., Rajani, C. S., Sabikhi, L. & Naik, N. L. Dipeptidyl peptidase-IV inhibitory potential of alpha-lactalbumin extracted from milk of Gir cows: A Bos indicus species. Int. J. Dairy. Technol. 75, 527–537. https://doi.org/10.1111/1471-0307.12868 (2022).
González-Montoya, M., Hernández-Ledesma, B., Mora-Escobedo, R. & Martínez-Villaluenga, C. Bioactive peptides from germinated soybean with anti-diabetic potential by Inhibition of dipeptidyl peptidase-IV, α-amylase, and α-glucosidase enzymes. Int. J. Mol. Sci. 19, 2883. https://doi.org/10.3390/ijms19102883 (2018).
Wang, B., Xie, N. & Li, B. Influence of peptide characteristics on their stability, intestinal transport, and in vitro bioavailability: A review. J. Food Biochem. 43, 1–6. https://doi.org/10.1111/jfbc.12571 (2019).
Agustia, F. C., Supriyadi, A., Murdiati, R. & Indrati Formation of dipeptidyl peptidase-IV (DPP-IV) inhibitory peptides from Jack bean (Canavalia ensiformis (L.) DC.) sprout in simulated digestion. Food Sci. Biotechnol. 33, 645–655. https://doi.org/10.1007/s10068-023-01343-9 (2023).
Liu, R., Cheng, J. & Wu, H. Discovery of food-derived dipeptidyl peptidase IV inhibitory peptides: A review. Int. J. Mol. Sci. 20, 463. https://doi.org/10.3390/ijms20030463 (2019).
Ojeda-Montes, M. J. et al. Activity and selectivity cliffs for DPP-IV inhibitors: lessons we can learn from SAR studies and their application to virtual screening. Med. Res. Rev. 38, 1874–1915. https://doi.org/10.1002/med.21499 (2018).
Matuszewska, E. et al. Mass spectrometry-based identification of bioactive bee pollen proteins: evaluation of allergy risk after bee pollen supplementation. Molecules 27, 7733. https://doi.org/10.3390/molecules27227733 (2022).
Kacemi, R. & Campos, M. G. Translational research on bee pollen as a source of nutrients: A scoping review from bench to real world. Nutrients 15, 2413. https://doi.org/10.3390/nu15102413 (2023).
Nongonierma, A. B. & FitzGerald, R. J. Strategies for the discovery and identification of food protein-derived biologically active peptides. Trends Food Sci. Technol. 69, 289e305. https://doi.org/10.1016/j.tifs.2017.03.003 (2017).
Cermeño, M. et al. Peptide identification from a Porphyra dioica protein hydrolysate with antioxidant, angiotensin converting enzyme and dipeptidyl peptidase IV inhibitory activities. Food Funct. 10, 3421–3429. https://doi.org/10.1039/c9fo00680j (2019).
Wang, W. et al. Identification and characterization of dipeptidyl peptidase-IV inhibitory peptides from oat proteins. Foods 11, 1406. https://doi.org/10.3390/foods11101406 (2022).
Zhang, A., Wang, K., Liu, X. & Zhang, X. Isolation and identification of dipeptidyl peptidase-IV inhibitory peptides from Sacha Inchi meal. J. Sci. Food Agric. 103, 2926–2938. https://doi.org/10.1002/jsfa.12464 (2023).
Nongonierma, A. B. et al. Dipeptidyl peptidase IV (DPP-IV) inhibitory properties of a camel Whey protein enriched hydrolysate Preparation. Food Chem. 279, 70–79. https://doi.org/10.1016/j.foodchem.2018.11.142 (2019).
Lin, Y. S., Han, C. H., Lin, S. Y. & Hou, W. C. Synthesized peptides from Yam Dioscorin hydrolysis in Silico exhibit dipeptidyl peptidase-IV inhibitory activities and oral glucose tolerance improvements in normal mice. J. Agric. Food Chem. 64, 6451–6458. https://doi.org/10.1021/acs.jafc.6b02403 (2016).
Jin, R., Teng, X., Shang, J., Wang, D. & Liu, N. Identification of novel DPP-IV inhibitory peptides from Atlantic salmon (Salmo salar) skin. Food Res. Int. 133, 109161. https://doi.org/10.1016/j.foodres.2020.109161 (2020).
Nongonierma, A. B., Lalmahomed, M., Paolella, S. & FitzGerald, R. J. Milk protein isolate (MPI) as a source of dipeptidyl peptidase IV (DPP-IV) inhibitory peptides. Food Chem. 231, 202–211. https://doi.org/10.1016/j.foodchem.2017.03.123 (2017).
Power, O., Fernandez, A., Norris, R. & Riera, F. A. Selective enrichment of bioactive properties during ultrafiltration of a tryptic digest of beta-lactoglobulin. J. Funct. Foods. 9, 38–47. https://doi.org/10.1016/j.jff.2014.04.002 (2014).
Ji, W., Zhang, C. & Ji, H. Two novel bioactive peptides from Antarctic Krill with dual angiotensin converting enzyme and dipeptidyl peptidase IV inhibitory activities. J. Food Sci. 82, 1742–1749. https://doi.org/10.1111/1750-3841.13735 (2017).
Rivero-Pino, F., Guadix, A. & Guadix, E. M. Identification of novel dipeptidyl peptidase IV and α-glucosidase inhibitory peptides from Tenebrio molitor. Food Funct. 12, 873–880. https://doi.org/10.1039/d0fo02696d (2021).
Zhang, M. et al. Food-derived dipeptidyl peptidase IV inhibitory peptides: Production, identification, structure-activity relationship, and their potential role in glycemic regulation. Crit. Rev. Food Sci. Nutr. 64, 2053–2075. https://doi.org/10.1080/10408398.2022.2120454 (2024).
Chen, Z. et al. The discovery and characterization of a potent DPP-IV inhibitory peptide from oysters for the treatment of type 2 diabetes based on computational and experimental studies. Mar. Drugs. 22, 361. https://doi.org/10.3390/md22080361 (2024).
Rodhi, A. M., Yap, P. G., Abayomi, O. O. & Gan, C. Y. A review on the types of amino acid at ultimate, penultimate and antepenultimate position in some dipeptidyl-peptidase IV inhibitory peptides based on molecular Docking analysis. Food Chem. Adv. 2, 100244. https://doi.org/10.1016/j.focha.2023.100244 (2023).
Wang, L. et al. Therapeutic peptides: current applications and future directions, signal transduct. Target. Ther. 7, 48. https://doi.org/10.1038/s41392-022-00904-4 (2022).
Song, T., Lv, M., Sun, B., Zheng, L. & Zhao, M. Tripeptides Val-Pro-Pro (VPP) and Ile-Pro-Pro (IPP) regulate the proliferation and migration of vascular smooth muscle cells by interfering Ang II-induced human umbilical vein endothelial cells derived EVs delivering RNAs to VSMCs in the co-culture model. J. Agric. Food Chem. 68, 6628–6637. https://doi.org/10.1021/acs.jafc.0c02060 (2020).
Chakrabarti, S., Guha, S. & Majumder, K. Food-derived bioactive peptides in human health: challenges and opportunities. Nutrients 10, 1738. https://doi.org/10.3390/nu10111738 (2018).
He, R. et al. Rapeseed protein-derived peptides, LY, RALP, and GHS, modulates key enzymes and intermediate products of renin-angiotensin system pathway in spontaneously hypertensive rat. NPJ Sci. Food. 3, 1. https://doi.org/10.1038/s41538-018-0033-5 (2019).
Mehrdadi, S. Lipid-based nanoparticles as oral drug delivery systems: overcoming poor Gastrointestinal absorption and enhancing bioavailability of peptide and protein therapeutics. Adv. Pharm. Bull. 14, 48–66. https://doi.org/10.34172/apb.2024.016 (2024).
Renukuntla, J., Vadlapudi, A. D., Patel, A., Boddu, S. H. & Mitra, A. K. Approaches for enhancing oral bioavailability of peptides and proteins. Int. J. Pharm. 447, 75–93. https://doi.org/10.1016/j.ijpharm.2013.02.030 (2013).
Arranz, E. et al. Dairy and plant based protein beverages: in vitro digestion behaviour and effect on intestinal barrier biomarkers. Food Res. Int. 169, 112815. https://doi.org/10.1016/j.foodres.2023.112815 (2023).
Khavinson, V., Linkova, N., Kozhevnikova, E., Dyatlova, A. & Petukhov, M. Transport of biologically active ultrashort peptides using POT and LAT carriers. Int. J. Mol. Sci. 23, 7733. https://doi.org/10.3390/ijms23147733 (2022).
Mathur, V. et al. Insight into structure activity relationship of DPP-4 inhibitors for development of antidiabetic agents. Molecules 28, 5860. https://doi.org/10.3390/molecules28155860 (2023).
Gu, H. et al. Dipeptidyl peptidase-IV inhibitory activity of millet protein peptides and the related mechanisms revealed by molecular Docking. LWT 138, 110587. https://doi.org/10.1016/j.lwt.2020.11058 (2021).
Li, Y., Zhang, F., Gong, J. & Peng, C. Two novel dipeptidyl peptidase-IV (DPP-IV) inhibitory peptides identified from truffle (Tuber sinense) by peptidomics, in silico, and molecular Docking analysis. J. Food Compos. Anal. 121, 105384. https://doi.org/10.1016/j.jfca.2023.105384 (2023).
Zan, R. et al. Identification of novel dipeptidyl peptidase-IV inhibitory peptides in Chickpea protein hydrolysates. J. Agric. Food Chem. 71, 8211–8219. https://doi.org/10.1021/acs.jafc.3c00603 (2023).
Zhang, M. et al. Rapid screening of novel dipeptidyl peptidase-4 inhibitory peptides from pea (Pisum sativum L.) protein using peptidomics and molecular Docking. J. Agric. Food Chem. 70, 10221–10228. https://doi.org/10.1021/acs.jafc.2c03949 (2022).
Zhang, S. et al. DPP-IV inhibitory peptides from Coix seed prolamins: Release, identification, and analysis of the interaction between key residues and enzyme domains. J. Agric. Food Chem. 71, 14575–14592. https://doi.org/10.1021/acs.jafc.3c02733 (2023).
Wu, W. et al. Identification and characterization of two novel dipeptidyl peptidase-IV inhibitory peptides from the simulated Gastrointestinal digestion of Tartary buckwheat proteins. Food Chem. 473, 143067. https://doi.org/10.1016/j.foodchem.2025.143067 (2025).
Li, J. et al. Screening, identification, and mechanistic exploration of DPP-IV inhibitory peptides from collagen in Esox Lucius skin. Food Biosci. 63, 105698. https://doi.org/10.1016/j.fbio.2024.105698 (2025).
Hu, H. et al. Identification and molecular mechanism of a novel DPP-IV inhibitory tetrapeptide IPVK from rabbit meat proteins: insights from in Silico study and experimental validation. Food Biosci. 63, 105766. https://doi.org/10.1016/j.fbio.2024.105766 (2025).
Xie, Y. et al. Preparation, characterization, and mechanism of DPP-IV inhibitory peptides derived from bactrian camel milk. Int. J. Biol. Macromol. 277 (Pt 3), 134232. https://doi.org/10.1016/j.ijbiomac.2024.134232 (2024).
Dang, K. et al. Screening and evaluation of novel DPP-IV inhibitory peptides in goat milk based on molecular Docking and molecular dynamics simulation. Food Chem. X. 25, 102217. https://doi.org/10.1016/j.fochx.2025.102217 (2025).
Mu, X. et al. Discovery of novel dipeptidyl peptidase-IV inhibitory peptides derived from walnut protein and their bioactivities in vivo and in vitro. Curr. Res. Food Sci. 9, 100893. https://doi.org/10.1016/j.crfs.2024.100893 (2024).
Mojica, L., Luna-Vital, D. A., Gonzalez de, E. & Mejia Black bean peptides inhibit glucose uptake in Caco-2 adenocarcinoma cells by blocking the expression and translocation pathway of glucose transporters. Toxicol. Rep. 5, 552–560. https://doi.org/10.1016/j.toxrep.2018.04.007 (2018).
Lammi, C. et al. Soybean- and lupin-derived peptides inhibit DPP-IV activity on in situ human intestinal Caco-2 cells and ex vivo human serum. Nutrients 10, 1082. https://doi.org/10.3390/nu10081082 (2018).
Alzaid, F., Cheung, H. M., Preedy, V. R. & Sharp, P. A. Regulation of glucose transporter expression in human intestinal Caco-2 cells following exposure to an anthocyanin-rich berry extract. PLoS One. 8, e78932. https://doi.org/10.1371/journal.pone.0078932 (2013).
Johnston, K., Sharp, P., Clifford, M. & Morgan, L. Dietary polyphenols decrease glucose uptake by human intestinal Caco-2 cells. FEBS Lett. 579, 1653–1657. https://doi.org/10.1016/j.febslet.2004.12.099 (2005).
Kwon, O. et al. Inhibition of the intestinal glucose transporter GLUT2 by flavonoids. FASEB J. 21, 366–377. https://doi.org/10.1096/fj.06-6620com (2007).
Vernaleken, A. et al. Tripeptides of RS1 (RSC1A1) inhibit a monosaccharide-dependent exocytotic pathway of Na+-D-glucose cotransporter SGLT1 with high affinity. J. Biol. Chem. 282, 28501–28513. https://doi.org/10.1074/jbc.M705416200 (2007).
Dugardin, C. et al. An exploratory study of the role of dietary proteins in the regulation of intestinal glucose absorption. Front. Nutr. 8, 769773. https://doi.org/10.3389/fnut.2021.769773 (2022).
Hiramatsu, H. et al. The crystal structure of human dipeptidyl peptidase IV (DPPIV) complex with Diprotin A. Biol. Chem. 385, 561–564. https://doi.org/10.1515/BC.2004.068 (2004).
Thoma, R. et al. Structural basis of proline-specific exopeptidase activity as observed in human dipeptidyl peptidase-IV. Structure 11, 947–959. https://doi.org/10.1016/s0969-2126(03)00160-6 (2003).
Watanabe, A. et al. The mechanism of sodium and substrate release from the binding pocket of vSGLT. Nature 468, 988–991. https://doi.org/10.1038/nature09580 (2010).
Deng, D. et al. Molecular basis of ligand recognition and transport by glucose transporters. Nature 526, 391–396. https://doi.org/10.1038/nature14655 (2015).
Acknowledgements
The authors wish to express their gratitude to the Institute of Biotechnology and Genetic Engineering at Chulalongkorn University for the use of the facilities which were necessary in order to complete this research study.
Funding
The authors wish to express their sincere gratitude to the 90th Anniversary of Chulalongkorn University Fund, Thailand (Ratchadaphiseksomphot Endowment Fund; GCUGR1125642023M), as well as and the Thailand Science Research and Innovation Fund Chulalongkorn University (BCG_FF_69_038_6100_002). for their financial assistance, without which the completion of this study would not have been feasible.
Author information
Authors and Affiliations
Contributions
Conceptualization: U.M., A.K.; Data curation: U.M.; Formal analysis: U.M.; Funding acquisition: A.K.; Investigation: A.K.; Methodology: U.M., K.K., P.S., T.S., P.B., O.R., P.Sr.; Project administration: A.K.; Resources: U.M., A.K.; Software: U.M., P.B., O.R., P.Sr.; Supervision: A.K.; Validation: U.M.; Visualization: U.M., O.R.; Writing – original draft: U.M., A.K.; Writing – review & editing: U.M., A.K.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethical approval
All methods were carried out in accordance with relevant guidelines and regulations. Plant experimental research, including the collection of plant material, complied with institutional, national, and international standards.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Mongkolnkrajang, U., Kuptawach, K., Sangtanoo, P. et al. Bee pollen-derived peptide with dual DPP-IV Inhibition and glucose transport modulation. Sci Rep (2026). https://doi.org/10.1038/s41598-026-39009-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-026-39009-1